- Global Pharma News & Resources

CPD Accredited: International Conference and Expo on Proteomics, Genomics, and Molecular Medicine

Join all major influencers of Biochemistry and Medicine at our CPD Accredited: International Conference and Expo on Proteomics, Genomics, and Molecular Medicine during March 09-10, 2020, Zurich, Switzerland.

Theme: “World of opportunities and Evolution in Proteomics and Molecular Medicine”

Research in the emerging field of proteomics is expanding at an extremely rapid rate. There are countless advances in this proteomics innovation, especially in the field of sub-atomic science. New proteomics and genomics advancements and creations could be utilized for ailment biomarker revelation and to screen tolerant reaction to the treatment. Applying genomic and proteomic strategies to body liquids and tissue concentrates would put profitable goal diagnostic force in the hands of the clinician however approval of those techniques is an imperative issue. The quick extension of the analytic apparatuses considering advancements in proteomics and genomic advances can be essential for the improvement of customized solution.

Global Proteomics Market

The Global proteomics market rate was valued at over $24,361million in 2017. Market rate is proceeding due to target diseases such as cancer, diabetes, cardiovascular and so on. The main aim of studying proteomics in the 21st century is to perceive the diseases at early stages. multiple reactions monitoring is the recent advancement in this field as it specifies the proteins present in the cerebrospinal fluid to dredge up multiple sclerosis in later stages.

The Global Proteomics market is segmented into Microarray, chromatography, x-ray crystallography, Immunoassay, Spectroscopy, protein fragmentation segments, Electrophoresis, and others. The reagent segment will lead overall proteomics market in the forecast period. proteomics market in terms of the product type is such as Instrumentation Technologies, Reagents, and Services.

 The Global Proteomics market is mainly segmented based on North America, Europe, Asia, Pacific, Latin America, Africa and the Middle East. Further, each region is hinged to provide global market revenue in countries such as India, Japan, U.S, Canada, U.K, Brazil and GCC countries.

Glance at Market of Proteomics:

The Global Proteomics business sector to develop at a CAGR of 8.39% over the period 2014-2019. Propels in mass spectrometry have revolved into a noteworthy figure for the improvement of the business sector as the information gave by these instruments are exceedingly exact and widely utilized for information Examination.

Increment popular for customized medications is one of the significant benefactors to the development of the business sector. Customized drugs are created by hereditary make-up of an individual, and today are broadly utilized for treatment of diabetes and diseases, for example, lung tumour.

Presentation Opportunities at Proteomics2020

 For Researchers and Faculty Members:

Speaker Presentations

Poster Display

Symposium hosting (4-5 member teams)

Workshop organizing

For Universities, Associations &Societies:

Association Partnering

Collaboration proposals         

Academic Partnering  

Group Participation

For Students and Research Scholars:

Poster Competition (Best poster award)        

Young Researchers Forum (YRF Award)

Student Attendee       

Group registrations

For Business Delegates:

Speaker Presentations

Symposium hosting   

Book Launch event   

Networking opportunities      

Audience participation

For Product Manufacturers:

Exhibitor and Vendor booths

Sponsorship opportunities

Product launch

Workshop organizing

Scientific Partnering
Marketing and Networking with clients


Contact Person:

Sandra Ross

Conference Director | Proteomics 2020

UK: 47, Churchfield Road, London, W36AY, UK

P: +44 20 3769 1755

Whats App: +44 20 3769 1755




CPD Accredited: International Conference and Expo on Proteomics, Genomics, and Molecular Medicine

Editor Details

Related Links

Last Updated: 12-Sep-2019